Home Menu

Site Navigation



NeuroTalk Support Groups > > >

Article : Off-Label Use of Atypical Antipsychotics

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 07-06-2007, 11:10 PM #1
Lara Lara is offline
Legendary
  
Join Date: Sep 2006
Posts: 11,026
15 yr Member
Lara Lara is offline
Legendary
 
Join Date: Sep 2006
Posts: 11,026
15 yr Member
Default Article : Off-Label Use of Atypical Antipsychotics
Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics: AHRQ Executive Summary
http://effectivehealthcare.ahrq.gov/...nal_Report.pdf
Full Text pdf
This is very long, but worth reading if you're interested. You can also just use the search feature to highlight keywords in the file e.g. Autism or Tourette's syndrome or PTSD etc..

from

Medscape Medical News
07/06/2007
Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics: AHRQ Executive Summary
http://www.medscape.com/viewarticle/559169_1
Lara is offline   Reply With QuoteReply With Quote
 

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Wondering About the Wonder Drugs: A Second Look at the Atypical Antipsychotics Chemar General Mental Health & Emotional Support 2 05-08-2007 09:11 AM


All times are GMT -5. The time now is 11:46 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home